Aspirochlorine: A highly selective and potent inhibitor of fungal protein synthesis

Journal of Antibiotics

Volumn 52, Issue 3, 1999, Pages 311-318

  Monti, Federica ^a,b   Ripamonti, Franca ^a   Hawser, Stephen P ^a,b   Islam, Khalid ^a,b  

^a Gruppo Lepetit SpA   (Italy)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASPIROCHLORINE; CHITIN; FUNGAL DNA; FUNGAL PROTEIN; FUNGAL RNA; GLIOTOXIN; GLUCAN; PROTEIN SYNTHESIS INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BACILLUS SUBTILIS; CANDIDA ALBICANS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG MECHANISM; NONHUMAN; PRIORITY JOURNAL; RNA SYNTHESIS;

CANDIDA ALBICANS;

EID: 0032927434     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.52.311     Document Type: Article

References (22)

1. KATO, A.; T. SAEKI, S. SUZUKI, K. ANDO & G. TAMURA: Oryzachlorine, a new antifungal antibiotic. J. Antibiotics 22: 322-326, 1969
2. BERG, D. H.; R. P. MASSING, M. M. HOEHN, L. D. BOECK & R. L. HAMILL: A 30641, a new epidithiodike-topiperazine with antifungal activity. J. Antibiotics 29: 394-397, 1976
3. SAKATA, K.; H. MASAGO, A. SAKURAI & N. TAKAHASHI: Isolation of aspirochlorine antibiotic A-30641 possessing a novel di thio di keto piperazine structure from Aspergillus flavis. Tetrahedron Letts. 23: 2095-2098, 1982
4. SAKATA, K.; T. KUWATSUKA, A. SAKURAI, N. TAKAHASHI & G. TAMURA: Isolation of aspirochlorine (=antibiotic A30641) as a true antimicrobial constituent of the antibiotic, oryzachlorine from Aspergillus oryzae. Agric. Biol. Chem. 47: 2673-2674, 1983
5. SAKATA, K.; M. MARUYAMA, J. UZAWA, A. SAKURAI, H. S. M. LU & J. CLARDY: Structural revision of aspirochlorine (= antibiotic A30641), a novel epidithiopiperazine-2,5-dione produced by Aspergillus spp. Tetrahedron Letts. 28: 5607-5610, 1987
6. WARING, P.; R. D. EICHNER & A. MULLBACHER: The chemistry and biology of the immunomodulating agent gliotoxin and related epipolythioxopiperazines. Med. Res. Rev. 8: 499-524, 1988
7. MULLBACHER, A.; P. WARING, U. TIWARI-PALNI & R. D. EICHNER: Structural relationship of epipolythiodioxopiperazines and their immunomodulating activity. Mol. Immunol. 23: 231-235, 1986
8. MULLBACHER, A.; D. HUME, A. W. BRAITHWAITE, P. WARING & R. D. EICHNER: Selective resistance of bone marrow-derived homopoietic progenitor cells to gliotoxin. Proc. Natl. Acad. Sci. 84:3822-3825, 1987
9. JORDAN, T. W. & S. J. CORDINER: Fungal epipolythiodioxopiperazine toxins have therapeutic potential and role in disease. TIPS 81: 144-149, 1987
10. EICHNER, R. D.; P. WARING, A. M. GEUE, A. W. BRAITHWAITE & A. MULLBACHER: Gliotoxin causes oxidative damage to plasmid and cellular DNA. J. Biol. Chem. 263: 3772-3777, 1988
11. MONTI, F.; F. RIPAMONTI, S. P. HAWSER & K. ISLAM: The antifungal compound aspirochlorine specifically inhibits fungal, but not mammalian or bacterial, protein synthesis. Abstracts of the 35th ICAAC, F-98, 162, Toronto, Canada, 1997
12. BARDONE, M. R.; E. MARTINELLI, L. F. ZERILLI & C. CORONELLI: Structure determination of purpuromycin, a new antibiotic. Tetrahedron Letts. 30: 2747-2754, 1974
13. ROJO, M. A.; F. J. ARIAS, R. MUNOZ, R. IGLESIAS, J. M. FERRERAS & T. GIRBES: Effect of fusidc acid on protein phosphorylation in several eukaryotic cell-free translation systems. Cellular & Molecular Biology 38: 171-174, 1992
14. RAMBELLI, F.; M. BRIGOTTI, M. ZAMBONI, M. DENARO, L. MONTANARO & S. SPERTI: Effect of the antibiotic purpuromycin on cell-free protein synthesising system. Biochem. J. 259:307-310, 1989
15. LANDINI, P.; E. CORTI, B. P. GOLDSTEIN & M. DENARO: Mechanism of action of purpuromycin. Biochem. J. 284:47-52, 1992
16. LANDINI, P.; A. SOFFIENTINI, F. MONTI, S. LOCIURO, E. MARZORATI & K. ISLAM: Antibiotic MDL 62,879 and kirromycin bind to distinct and independent sites on elongation factor Tu(EF-Tu). Biochemistry 35: 15288-15294, 1996
17. MOLDAVE, K.: Eukaryotic protein synthesis. Annu. Rev. Biochem. 54: 1109-1149, 1985
18. QIN, S.; A. XIE, M. C. M. BONATO & C. S. MCLAUGHLIN: Sequence analysis of the translational elongation factor 3 from Saccharomyces cerevisiae. J. Biol. Chem. 265: 1903-1912, 1990
19. COLTHURST, D. R.; M. SANTOS, C. M. GRANT & M. F. TUITE: Candida albicans and three other Candida spp. Contain an elongation factor structurally and functionally analogous to elongation factor 3. FEMS Microbiol. Letts. 80: 45-50, 1991
20. KAMATH, A. & K. CHAKRABURTTY: Role of yeast elongation factor 3 in the elongation cycle. J. Biol. Chem. 264: 15423-15428, 1989
21. BROWN, G. E.; A. J. KOLB & W. M. STANLEY, JR.: A general procedure for the preparation of highly active eukaryotic ribosomes and ribosomal subunits. Methods in Enzymology 30: 368-387, 1974
22. SELVA, E.; G. BERETTA, N. MONTANINI, G. S. SADDLER, L. GASTALDO, P. FERRARI, R. LORENZETTI, P. LANDINI, F. RIPAMONTI, B. P. GOLDSTEIN, M. BERTI, L. MONTANARO & M. DENARO: Antibiotic GE2270 A: a novel inhibitor of bacterial protein synthesis. I. Isolation and characterization. J. Antibiotics 44: 693-701, 1991